• Most Popular
  • Most Shared

UPDATE 1-Vanda says FDA accepts schizophrenia drug response

Thu Nov 20, 2008 9:33am EST

Stocks

   

(Recasts; adds details, stock movement)

Stocks  |  Regulatory News

Nov 20 (Reuters) - Vanda Pharmaceuticals Inc (VNDA.O) said U.S. health regulators accepted the complete response for its experimental schizophrenia drug, iloperidone, sending its shares up 40 percent in pre-market trade.

The company, which received a not-approvable letter for the drug from the U.S. Food and Drug Administration in July, said the FDA has set May 6 as a new target action date to complete the review of the drug. Shares of the company were trading at 95 cents before the bell, up from their Wednesday close of 68 cents on Nasdaq. (Reporting by Esha Dey in Bangalore; Editing by Pratish Narayanan)

Stocks
Regulatory News


More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets